Juan F Burgueño1, Julia Fritsch2, Eddy E González3, Kevin S Landau1, Ana M Santander1, Irina Fernández1, Hajar Hazime1, Julie M Davies1, Rebeca Santaolalla1, Matthew C Phillips1, Sophia Diaz1, Rishu Dheer1, Nivis Brito1, Judith Pignac-Kobinger1, Ester Fernández4, Gregory E Conner5, Maria T Abreu6. 1. Department of Medicine, Division of Gastroenterology, University of Miami-Miller School of Medicine, Miami, Florida. 2. Department of Medicine, Division of Gastroenterology, University of Miami-Miller School of Medicine, Miami, Florida; Department of Microbiology and Immunology, University of Miami-Miller School of Medicine, Miami, Florida. 3. Biotechnology and Biopharmaceuticals Laboratory, Department of Pathophysiology, School of Biological Science, Universidad de Concepción, Concepción, Chile. 4. Animal Physiology Unit, Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Barcelona, Spain. 5. Department of Cell Biology, University of Miami-Miller School of Medicine, Miami, Florida. 6. Department of Medicine, Division of Gastroenterology, University of Miami-Miller School of Medicine, Miami, Florida; Department of Microbiology and Immunology, University of Miami-Miller School of Medicine, Miami, Florida. Electronic address: Mabreu1@med.miami.edu.
Abstract
BACKGROUND & AIMS: Chronic colonic inflammation leads to dysplasia and cancer in patients with inflammatory bowel disease. We have described the critical role of innate immune signaling via Toll-like receptor 4 (TLR4) in the pathogenesis of dysplasia and cancer. In the current study, we interrogate the intersection of TLR4 signaling, epithelial redox activity, and the microbiota in colitis-associated neoplasia. METHODS: Inflammatory bowel disease and colorectal cancer data sets were analyzed for expression of TLR4, dual oxidase 2 (DUOX2), and NADPH oxidase 1 (NOX1). Epithelial production of hydrogen peroxide (H2O2) was analyzed in murine colonic epithelial cells and colonoid cultures. Colorectal cancer models were carried out in villin-TLR4 mice, carrying a constitutively active form of TLR4, their littermates, and villin-TLR4 mice backcrossed to DUOXA-knockout mice. The role of the TLR4-shaped microbiota in tumor development was tested in wild-type germ-free mice. RESULTS: Activation of epithelial TLR4 was associated with up-regulation of DUOX2 and NOX1 in inflammatory bowel disease and colorectal cancer. DUOX2 was exquisitely dependent on TLR4 signaling and mediated the production of epithelial H2O2. Epithelial H2O2 was significantly increased in villin-TLR4 mice; TLR4-dependent tumorigenesis required the presence of DUOX2 and a microbiota. Mucosa-associated microbiota transferred from villin-TLR4 mice to wild-type germ-free mice caused increased H2O2 production and tumorigenesis. CONCLUSIONS: Increased TLR4 signaling in colitis drives expression of DUOX2 and epithelial production of H2O2. The local milieu imprints the mucosal microbiota and imbues it with pathogenic properties demonstrated by enhanced epithelial reactive oxygen species and increased development of colitis-associated tumors. The inter-relationship between epithelial reactive oxygen species and tumor-promoting microbiota requires a 2-pronged strategy to reduce the risk of dysplasia in colitis patients.
BACKGROUND & AIMS: Chronic colonic inflammation leads to dysplasia and cancer in patients with inflammatory bowel disease. We have described the critical role of innate immune signaling via Toll-like receptor 4 (TLR4) in the pathogenesis of dysplasia and cancer. In the current study, we interrogate the intersection of TLR4 signaling, epithelial redox activity, and the microbiota in colitis-associated neoplasia. METHODS: Inflammatory bowel disease and colorectal cancer data sets were analyzed for expression of TLR4, dual oxidase 2 (DUOX2), and NADPH oxidase 1 (NOX1). Epithelial production of hydrogen peroxide (H2O2) was analyzed in murine colonic epithelial cells and colonoid cultures. Colorectal cancer models were carried out in villin-TLR4 mice, carrying a constitutively active form of TLR4, their littermates, and villin-TLR4 mice backcrossed to DUOXA-knockout mice. The role of the TLR4-shaped microbiota in tumor development was tested in wild-type germ-free mice. RESULTS: Activation of epithelial TLR4 was associated with up-regulation of DUOX2 and NOX1 in inflammatory bowel disease and colorectal cancer. DUOX2 was exquisitely dependent on TLR4 signaling and mediated the production of epithelial H2O2. Epithelial H2O2 was significantly increased in villin-TLR4 mice; TLR4-dependent tumorigenesis required the presence of DUOX2 and a microbiota. Mucosa-associated microbiota transferred from villin-TLR4 mice to wild-type germ-free mice caused increased H2O2 production and tumorigenesis. CONCLUSIONS: Increased TLR4 signaling in colitis drives expression of DUOX2 and epithelial production of H2O2. The local milieu imprints the mucosal microbiota and imbues it with pathogenic properties demonstrated by enhanced epithelial reactive oxygen species and increased development of colitis-associated tumors. The inter-relationship between epithelial reactive oxygen species and tumor-promoting microbiota requires a 2-pronged strategy to reduce the risk of dysplasia in colitis patients.
Authors: Masayuki Fukata; Limin Shang; Rebeca Santaolalla; John Sotolongo; Cristhine Pastorini; Cecilia España; Ryan Ungaro; Noam Harpaz; Harry S Cooper; Greg Elson; Marie Kosco-Vilbois; Julia Zaias; Maria T Perez; Lloyd Mayer; Arunan S Vamadevan; Sergio A Lira; Maria T Abreu Journal: Inflamm Bowel Dis Date: 2010-11-15 Impact factor: 5.325
Authors: Nicolae Corcionivoschi; Luis A J Alvarez; Thomas H Sharp; Monika Strengert; Abofu Alemka; Judith Mantell; Paul Verkade; Ulla G Knaus; Billy Bourke Journal: Cell Host Microbe Date: 2012-07-19 Impact factor: 21.023
Authors: Mathias L Richard; Giuseppina Liguori; Bruno Lamas; Giovanni Brandi; Gregory da Costa; Thomas W Hoffmann; Massimo Pierluigi Di Simone; Carlo Calabrese; Gilberto Poggioli; Philippe Langella; Massimo Campieri; Harry Sokol Journal: Gut Microbes Date: 2017-10-12
Authors: Luis A Alvarez; Lidija Kovačič; Javier Rodríguez; Jan-Hendrik Gosemann; Malgorzata Kubica; Gratiela G Pircalabioru; Florian Friedmacher; Ada Cean; Alina Ghişe; Mihai B Sărăndan; Prem Puri; Simon Daff; Erika Plettner; Alex von Kriegsheim; Billy Bourke; Ulla G Knaus Journal: Proc Natl Acad Sci U S A Date: 2016-08-25 Impact factor: 11.205
Authors: Jacob Sabates-Bellver; Laurens G Van der Flier; Mariagrazia de Palo; Elisa Cattaneo; Caroline Maake; Hubert Rehrauer; Endre Laczko; Michal A Kurowski; Janusz M Bujnicki; Mirco Menigatti; Judith Luz; Teresa V Ranalli; Vito Gomes; Alfredo Pastorelli; Roberto Faggiani; Marcello Anti; Josef Jiricny; Hans Clevers; Giancarlo Marra Journal: Mol Cancer Res Date: 2007-12 Impact factor: 5.852
Authors: Rishu Dheer; Rebeca Santaolalla; Julie M Davies; Jessica K Lang; Matthew C Phillips; Cristhine Pastorini; Maria T Vazquez-Pertejo; Maria T Abreu Journal: Infect Immun Date: 2016-01-11 Impact factor: 3.441
Authors: Adam P Levine; Nikolas Pontikos; Elena R Schiff; Luke Jostins; Doug Speed; Laurence B Lovat; Jeffrey C Barrett; Helmut Grasberger; Vincent Plagnol; Anthony W Segal Journal: Gastroenterology Date: 2016-07-01 Impact factor: 22.682
Authors: Cody A Despins; Scott D Brown; Avery V Robinson; Andrew J Mungall; Emma Allen-Vercoe; Robert A Holt Journal: mBio Date: 2021-10-26 Impact factor: 7.867
Authors: Gillian E Jacobsen; Irina Fernández; Maria A Quintero; Ana M Santander; Judith Pignac-Kobinger; Oriana M Damas; Amar R Deshpande; David H Kerman; Yuguang Ban; Zhen Gao; Tiago C Silva; Lily Wang; Ashley H Beecham; Jacob L McCauley; Juan F Burgueño; Maria T Abreu Journal: Gastro Hep Adv Date: 2022-03-30